# SAP25

## Overview
SAP25, or Sin3A associated protein 25, is a gene that encodes an adaptor protein integral to the Sin3/HDAC complex, a key player in transcriptional regulation and chromatin remodeling. The SAP25 protein facilitates the recruitment of various enzymatic and regulatory complexes, influencing processes such as ubiquitination, deubiquitination, and O-GlcNAcylation. It does not directly bind DNA but acts as a docking protein, interacting with multiple partners, including histone deacetylases, O-GlcNAc transferase, and ubiquitin carboxyl-terminal hydrolase 11. These interactions underscore its role in transcriptional repression and DNA damage repair. Clinically, SAP25 is implicated in cancer, particularly breast cancer, where its expression levels correlate with survival disparities. Additionally, it is associated with immune response regulation and inflammatory conditions, highlighting its potential as a therapeutic target (Goswami2024Distinct; Adams2018Co-repressor; Lee2022Association).

## Structure
SAP25 (Sin3A associated protein 25) is a protein that functions as an adaptor within the Sin3/HDAC complex, facilitating the recruitment of various enzymatic complexes. The primary structure of SAP25 includes distinct regions responsible for specific interactions: the C-terminal region, particularly amino acids 149-150, is crucial for binding with the Sin3 complex, while the N-terminal region, specifically amino acids 16-30, interacts with the SCF(FBXO3) complex (Goswami2024Distinct). The central region, encompassing amino acids 50-130, is involved in capturing OGT/TET and USP11 proteins (Goswami2024Distinct).

The secondary and tertiary structures of SAP25 are not explicitly detailed in the available context. However, the protein's modular structure suggests that it may have distinct domains facilitating multiple protein interactions, acting as a platform for assembling complexes independently but in proximity (Goswami2024Distinct).

SAP25 is involved in post-translational modifications, including ubiquitination, deubiquitination, and O-GlcNAcylation, which are crucial for its function in transcriptional regulation and chromatin remodeling (Goswami2024Distinct). The protein does not have recognizable DNA-binding motifs, supporting its role as a docking protein rather than a direct DNA-binding entity (Goswami2024Distinct).

## Function
SAP25 (Sin3A associated protein 25) functions as an adaptor protein within the Sin3/HDAC complex, playing a crucial role in transcriptional regulation by recruiting various enzymatic and regulatory complexes. It is involved in chromatin remodeling and gene silencing through interactions with histone deacetylases (HDACs) (Goswami2024Distinct; Grzenda2009Sin3:). SAP25 recruits O-GlcNAc transferase (OGT), TET methylcytosine dioxygenases, SCF E3 ubiquitin ligase complex, and ubiquitin carboxyl-terminal hydrolase 11 (USP11) to the Sin3/HDAC complex, influencing post-translational modifications such as ubiquitination, deubiquitination, O-GlcNAcylation, and deacetylation (Goswami2024Distinct).

Distinct regions of SAP25 are responsible for these interactions, with the C-terminus interacting with the Sin3 complex, the N-terminus associating with SCF(FBXO3), and a central region capturing OGT/TET and USP11 (Goswami2024Distinct). SAP25's interaction with USP11 suggests a role in coordinating transcriptional repression with DNA damage repair (Goswami2024Distinct). It also interacts with LIM domain proteins involved in cellular signaling and structural organization, indicating broader roles in cellular processes beyond transcriptional regulation (Goswami2024Distinct). SAP25 is active in the nucleus, where it influences gene expression and cellular differentiation processes (Adams2018Co-repressor).

## Clinical Significance
SAP25 has been implicated in various diseases and conditions due to its role in transcriptional regulation and interaction with the Sin3/HDAC complex. Alterations in SAP25 expression have been associated with cancer, particularly breast cancer. In breast cancer, SAP25 is linked to cancer survival disparities, with increased expression observed in individuals of African ancestry compared to those of European ancestry. This increased expression is associated with a higher relative risk of death, suggesting a significant impact on survival outcomes (Lee2022Association).

SAP25's interactions with proteins involved in glycosylation, DNA demethylation, and ubiquitination, such as OGT, TET2/3, FBXO3, and USP11, suggest its involvement in transcriptional repression and DNA damage repair. These interactions may contribute to its role in cancer-related pathways, including breast cancer metastasis (Goswami2024Distinct).

Additionally, SAP25 has been associated with immune response regulation and inflammatory conditions, such as inflammatory bowel diseases and Alzheimer's disease, indicating its broader clinical significance beyond cancer (Goswami2024Distinct). The potential for SAP25 to serve as a target for cancer therapy is highlighted by its role in transcription repression and tumorigenesis (Lee2022Association).

## Interactions
SAP25 (Sin3A associated protein 25) is known for its role as an adaptor protein within the Sin3/HDAC complex, facilitating interactions with various enzymatic and regulatory protein complexes. It interacts with the Sin3/HDAC complex through its C-terminal region, specifically binding to the SIN3A scaffold subunit (Goswami2024Distinct). SAP25 also associates with the SCF(FBXO3) E3 ubiquitin ligase complex via its N-terminal region, which includes subunits FBXO3, SKP1, and CUL1 (Goswami2024Distinct).

The central region of SAP25 is crucial for interactions with O-GlcNAc transferase (OGT) and TET methylcytosine dioxygenases, as well as the deubiquitinase USP11 (Goswami2024Distinct). These interactions are independent of the Sin3 complex, suggesting that SAP25 can recruit these complexes to the Sin3/HDAC complex, potentially influencing transcriptional repression and chromatin modification (Goswami2024Distinct).

SAP25's interaction with the Sin3 complex is mediated by its Sin3 interaction domain (SID), which binds specifically to the PAH1 domain of Sin3A, forming a type-II orientation similar to that of Tet1-SID (Adams2018Co-repressor; Chandru2018Sin3A).


## References


1. (Goswami2024Distinct) Distinct regions within SAP25 recruit O-linked glycosylation, DNA demethylation, and ubiquitin ligase and hydrolase activities to the Sin3/HDAC complex. This article has 0 citations.

[2. (Chandru2018Sin3A) Aditya Chandru, Neil Bate, Geerten W. Vuister, and Shaun M. Cowley. Sin3a recruits tet1 to the pah1 domain via a highly conserved sin3-interaction domain. Scientific Reports, October 2018. URL: http://dx.doi.org/10.1038/s41598-018-32942-w, doi:10.1038/s41598-018-32942-w. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-018-32942-w)

[3. (Lee2022Association) Kara Keun Lee, Lavanya Rishishwar, Dongjo Ban, Shashwat Deepali Nagar, Leonardo Mariño-Ramírez, John F. McDonald, and I. King Jordan. Association of genetic ancestry and molecular signatures with cancer survival disparities: a pan-cancer analysis. Cancer Research, 82(7):1222–1233, January 2022. URL: http://dx.doi.org/10.1158/0008-5472.CAN-21-2105, doi:10.1158/0008-5472.can-21-2105. This article has 21 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.CAN-21-2105)

[4. (Adams2018Co-repressor) Grace E. Adams, Aditya Chandru, and Shaun M. Cowley. Co-repressor, co-activator and general transcription factor: the many faces of the sin3 histone deacetylase (hdac) complex. Biochemical Journal, 475(24):3921–3932, December 2018. URL: http://dx.doi.org/10.1042/bcj20170314, doi:10.1042/bcj20170314. This article has 99 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bcj20170314)

[5. (Grzenda2009Sin3:) Adrienne Grzenda, Gwen Lomberk, Jin-San Zhang, and Raul Urrutia. Sin3: master scaffold and transcriptional corepressor. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1789(6–8):443–450, June 2009. URL: http://dx.doi.org/10.1016/j.bbagrm.2009.05.007, doi:10.1016/j.bbagrm.2009.05.007. This article has 200 citations.](https://doi.org/10.1016/j.bbagrm.2009.05.007)